LCM
CASC

Laurion Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Laurion Capital Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-260,710
Closed -$965K – 1496
2017
Q4 		$965K Buy
+260,710
New +$965K ﹤0.01% 589
2016
Q3 		– Sell
-45,517
Closed -$258K – 852
2016
Q2 		$258K Buy
+45,517
New +$258K ﹤0.01% 389